From the publishers of JADPRO

HR+ HER2- Breast Cancer Resource Center

Advertisement
Videos
Interview with Dr. Ashley Martinez: Breast Cancer During Pregnancy
Interview with Sanita Burgic, MSN, APRN, AGNP-C: Highlights from the 2026 ASCO Annual Meeting
Interview with Amy E. Cyr, MD, FACS: Personalization of Management for High-Risk Women
Interview with Amy E. Cyr, MD, FACS: Identification and Management for High-Risk Women
Interview with Ashley Frith, MD: Metastatic Disease Research Highlights from the 2025 San Antonio Breast Cancer Symposium
Interview with Ashley Frith, MD: Early-Stage Disease Research Highlights from the 2025 San Antonio Breast Cancer Symposium
Beyond HER2-Low: Understanding the Emerging HER2–Ultra Low Classification
Interview with Michelle Kirschner RN, MSN, ACNP, APRN-BC: Use of the Breast Cancer Index in Guiding Extended Endocrine Therapy
Interview with Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP: Bone Health During Breast Cancer Treatment
Highlights from the 2025 ASCO Annual Meeting: Part 2
Highlights from the 2025 ASCO Annual Meeting: Part 1
Redefining the Treatment Landscape: HER2-Low and Its Implications for HR+ HER2- Metastatic Breast Cancer
Interview with Antonia Corrigan MSN, ANP-C, ACHPN: Adverse Event Management for Breast Cancer Treatment
Interview with Antonia Corrigan, MSN, ANP-C, ACHPN: The Psychosocial Effects of Breast Cancer and its Treatment
Early-Stage Disease Research Highlights from 2024 San Antonio Breast Cancer Symposium
Metastatic Disease Research Highlights from the 2024 San Antonio Breast Cancer Symposium
Interview with Stephanie Giangiuli, PharmD, BCOP: Oral Therapies and Side Effect Management in HR+ HER2- Breast Cancer
Interview with Stephanie Giangiuli, PharmD, BCOP: IV Therapies and Side Effect Management in HR+ HER2- Breast Cancer
Brain Metastases in HR+ HER2- Breast Cancer
Introduction to HR+ HER2- Breast Cancer
Advertisement
Case Studies

Managing Adverse Events for Women Receiving Adjuvant Breast Cancer Treatment

Seeing the Whole Picture: Labs, Circulating Tumor DNA, Imaging, and Clinical Advocacy in the Management of Recurrent HR+ HER2- Breast Cancer

Navigating Treatment Adherence in Early-Stage Breast Cancer

Advertisement
Quizzes
Test your knowledge of adverse event management for women receiving adjuvant breast cancer treatment
Test your knowledge of labs, ctDNA, imaging, and clinical advocacy in the management of recurrent HR+ HER2- breast cancer
Test your knowledge of treatment adherence in early-stage breast cancer